Brugia malayi: ivermectin inhibits the exsheathment of microfilariae.
Brugia malayi-infected microfilaremic jirds (Meriones unguiculatus) were treated with ivermectin at a single dose of 200 micrograms/kg of body weight injected subcutaneously. Susceptible Aedes aegypti mosquitoes were fed on treated jirds 24 hours later. Mosquitoes fed on untreated jirds served as controls. Infected mosquitoes were dissected at 1, 3, 24, 48, 72, and 96 hr after the blood meal, and differential counts of sheathed microfilariae, exsheathed microfilariae, and cast sheaths were performed using fluoresceinated wheat germ agglutinin. Microfilariae failed to exsheath in mosquitoes fed on ivermectin-treated jirds. Microfilariae from ivermectin-treated jirds also did not exsheath in vitro in the presence of 10 mM CaCl2, whereas 85-90% of sheathed microfilariae from untreated jirds exsheathed in vitro. In addition, sheathed microfilariae from untreated jirds, when pretreated in vitro with ivermectin at 0.25, 0.5, or 1 microgram/ml, lost their ability to exsheath in vitro in the presence of 10 mM CaCl2. However, ivermectin treatment had no effect on exsheathing of microfilariae when incubated with papaya protease. Thus, ivermectin appears to inhibit the intrinsic exsheathing process of microfilariae in the mosquito host, thereby blocking their development and further transmission of infection.
Rao
U R
UR
Department of Environmental and Occupational Health, College of Public Health, University of South Florida, Tampa.
Vickery
A C
AC
Kwa
B H
BH
Nayar
J K
JK
D000330:Aedes / Q000469:parasitology; D000818:Animals; D002009:Brugia / Q000187:drug effects*; D005849:Gerbillinae / Q000469:parasitology; D007559:Ivermectin / Q000494:pharmacology*; D008297:Male; D008842:Microfilariae / Q000187:drug effects* / Q000502:physiology
D007559:Ivermectin